Literature DB >> 525998

Pharmacokinetics of cefamandole and ampicillin in experimental meningitis.

H N Beaty, E Walters.   

Abstract

The penetration of cefamandole and ampicillin into the cerebrospinal fluid of rabbits with and without pneumococcal meningitis was evaluated. In normal animals, a mean maximum concentration of 0.22 +/- 0.13 microgram of cefamandole per ml was measured in the spinal fluid after a dose of 150 mg/kg given intramuscularly; with 25 and 50 mg/kg doses, no antibiotic was detected in the cerebrospinal fluid. With ampicillin, in intramuscular doses of 200 and 300 mg/kg, the mean maximum concentrations encountered in the cerebrospinal fluid were 1.59 +/- 0.4 and 1.47 +/- 0.44 microgram/ml, respectively. Penetration of cefamandole, and to a lesser extent ampicillin, was increased after 24 h of experimental meningitis. With cefamandole, the concentration of drug in the cerebrospinal fluid exceeded the usual inhibitory concentration for Haemophilus influenzae only with the 150 mg/kg dose. After 48 h of meningitis, there was a trend toward higher levels of antibiotic in the cerebrospinal fluid, but the difference between animals infected 24 versus 48 h was not statistically significant. In animals with meningitis, serum concentrations after 150 mg of cefamandole per kg and both ampicillin doses studied were 32 to 38% lower than the serum levels achieved in normal rabbits after identical doses of antibiotic.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525998      PMCID: PMC352909          DOI: 10.1128/AAC.16.5.584

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Experimental pneumococcal meningitis. II. Characterization and quantitation of the inflammatory process.

Authors:  C K McAllister; J M O'Donoghue; H N Beaty
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

2.  Penetration of cefamandole into spinal fluid.

Authors:  E A Steinberg; G D Overturf; L J Baraff; J Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

3.  Blood, brain, and cerebrospinal fluid concentrations of several antibiotics in rabbits with intact and inflamed meninges.

Authors:  T R Beam; J C Allen
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

4.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

5.  Failure of cefamandole in treatment of meningitis due to Haemophilus influenzae type b.

Authors:  E A Steinberg; G D Overturf; J Wilkins; L J Baraff; J M Streng; J M Leedom
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

6.  Evaluation of cefamandole therapy of patients with bacterial meningitis.

Authors:  O M Korzeniowski; E M Carvalho; H Rocha; M A Sande
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

7.  Experimental pneumococcal meningitis I: a rabbit model.

Authors:  J M O'Donoghue; A I Schweid; H N Beaty
Journal:  Proc Soc Exp Biol Med       Date:  1974-06

8.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

9.  Gentamicin sulfate pharmacokinetics: lower levels of gentamicin in blood during fever.

Authors:  J E Pennington; D C Dale; H Y Reynolds; J D MacLowry
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

10.  Cephalosporin antibiotics in therapy of experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis in rabbits.

Authors:  M A Sande; R J Sherertz; O Zak; L J Strausbaugh
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

  10 in total
  1 in total

1.  Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.

Authors:  G H McCracken; J D Nelson; L Grimm
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.